MapLight Therapeutics MPLT
NASDAQ MPLT
$7.66 +0.22 (+3.02%)
As of: Nov 11, 2026 · 10:13 AM EST

MapLight Therapeutics (MPLT) Cash from Financing Activities (2024 - 2026)

Updated

MapLight Therapeutics' Cash from Financing Activities was $271.97 million in Q4 2025, compared with $5,000 a year earlier and up 37.3% from the prior quarter.

Analysis

MapLight Therapeutics (MPLT) Cash from Financing Activities (2024 - 2026) Analysis & Trends

For FY2025, Cash from Financing Activities at MapLight Therapeutics came in at $469.82 million, up 298.0% from FY2024.

  • In earlier years, Cash from Financing Activities was $118.06 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -8.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.82 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -1.53 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.51 Bn
10 MapLight Therapeutics 338.05 Mn 33.33 Mn - 92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,000.00
Mar 31, 2026 -6.85 Mn
Dec 31, 2025 271.97 Mn
Sep 30, 2025 198.06 Mn
Jun 30, 2025 -156,000.00
Mar 31, 2025 -47,000.00
Dec 31, 2024 5,000.00
API Access

MapLight Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=MPLT&period=max&api_key=YOUR_API_KEY